Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Allergan Aesthetics reports improved facial satisfaction in GLP-1 users after aesthetic treatments


Camzyos shows sustained benefit through 56 weeks in paediatric obstructive HCM


Livdelzi improves ALP normalisation rates in Phase III PBC study


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Innovative solutions from Industry 4.0

Presented by Michael May, PhD, President and CEO, CCRM at Centre For Commercialization Of Regenerative Medicine and Philip G. Vanek, PhD, General Manager, Cell and Gene Therapy Strategy at GE
10th June 2019


Transformation of Toxicology data into Specific PDE’s

Presented by Kim Li, PhD, DABT, MPH Principal Scientist, EHSS Product Stewardship Toxicology at Amgen Inc and Dries Cardoen, Team Leader of Study Directors at Nelson Laboratories, LLC
23rd April 2020


Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity

Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics at Novartis and Beate Kern, Product Manager at NanoTemper Technologies
27th September 2018


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia